Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779270 · ClinicalTrials.gov registry record · NA
Test the Outdoor Usage for Sunscreen Products in Female Adults
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT02779270: Completed NA study, sponsored by Bayer.
NCT02779270 is a NA study that has completed, run by Bayer. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02779270, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
To assess the safety of a sunscreen product when used outdoor.
Interventions
- DRUG BAY987518
- DRUG Sunscreen Lotion (U77-030 Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2015-09-26 |
| Est. Completion | 2015-09-27 |
| Phase | NA |
What the finished NCT02779270 record still lists
NCT02779270 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which BAY987518 is the first listed.
NCT02779270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02779270 about?
NCT02779270 is a clinical study titled "Test the Outdoor Usage for Sunscreen Products in Female Adults". To assess the safety of a sunscreen product when used outdoor.
What is the current status of trial NCT02779270?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2015-09-26. Estimated completion is 2015-09-27.
What interventions are being tested in trial NCT02779270?
The interventions under investigation include: BAY987518 (DRUG), Sunscreen Lotion (U77-030 Control) (DRUG).
Who is sponsoring clinical trial NCT02779270?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02779270's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI